Related Experiment Videos
[Nifedipine in hypertrophic obstructive cardiomyopathy]
Deutsche Medizinische Wochenschrift (1946)
|December 3, 1982
Summary
Nifedipine effectively reduces outflow obstruction and increases cardiac output in patients with hypertrophic obstructive cardiomyopathy (HOCM). This calcium channel blocker also dilates coronary arteries, potentially preventing coronary spasms and angina.
Area of Science:
- Cardiology
- Pharmacology
Context:
- Hypertrophic obstructive cardiomyopathy (HOCM) is characterized by left-ventricular outflow obstruction.
- Assessing the hemodynamic effects of nifedipine in HOCM patients is crucial for understanding its therapeutic potential.
Purpose:
- To evaluate the impact of nifedipine on left-ventricular dynamics and outflow obstruction in patients with HOCM.
Summary:
- Intravenous nifedipine (3 mg) administration in 6 HOCM patients resulted in decreased mean aortic pressure and increased heart rate.
- Cardiac index significantly increased, while stroke volume index decreased. Outflow obstruction diminished, and left-ventricular end-diastolic pressure rose.
- Coronary sinus oxygen saturation increased, indicating coronary vasodilation, which may offer protection against coronary spasms and angina.
Impact:
- Nifedipine demonstrates efficacy in reducing outflow obstruction and augmenting cardiac output in HOCM.
- Coronary vasodilation induced by nifedipine may provide antianginal benefits in HOCM patients.
- The findings support nifedipine as a potential therapeutic agent for managing HOCM symptoms.